ABCZF News and Press, Abcam PLC

2024-01-18 08:45:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The Headwaters Capital Management, LLC (“Headwaters Capital,” “Headwaters,” or the ...

2023-11-19 07:11:04 ET Summary Top merger stocks held by funds include Seagen and VMware, with pending deals expected to close soon. Market uncertainty surrounding the VMware merger has led to a perplexing stock price for its shares. Looking at the top holdings of arb hedge fu...

2023-07-28 09:00:00 ET Summary Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The portfolio gained +17.4% (17.2% net) for the second quarter of 2023 compared to a +4.8% return for the Russell M...

Abcam Announces Review of Strategic Alternatives PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , June 23, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today anno...

2023-06-09 09:00:00 ET Summary Abcam plc's outlook remains unchanged after a mixed FY'22, with improvements needed in fundamental, sentiment, and valuation factors to attract buyers. Despite a strong FY'22, ABCM's poor returns on capital, economic losses and flat growth outlook hi...

ABCAM PLC Result of Annual General Meeting PR Newswire CAMBRIDGE, England and WALTHAM, Mass , May 17, 2023 /PRNewswire/ --  Abcam plc (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces the voting results from the Annu...

ABCAM PLC: Upcoming Abcam Investor Events PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , April 17, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces ...

Abcam to Report Full Year Results on Monday, March 20, 2023 PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , March 10, 2023 /PRNewswire/ -- Abcam plc (Nasdaq: ABCM) (" Abcam " or the " Company "), a global leader in the supply of life science resea...

Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...

Summary Vir Biotechnology is a commercial-stage immunology company that bases its activity on infectious disease prevention. The agreement with GSK made it possible to obtain large revenues and profits in 2022. A good pipeline allows us to assume high growth in the coming years. ...